SENSI, ELISA Statistiche
SENSI, ELISA
Feasibility of BRCA1/2 testing of formalin-fixed and paraffin-embedded pancreatic tumor samples: A consecutive clinical series
2021-01-01 Bruno, R.; Sensi, E.; Lupi, C.; Giordano, M.; Bernardini, L.; Vivaldi, C.; Fornaro, L.; Vasile, E.; Campani, D.; Fontanini, G.
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial
2019-01-01 Cremolini, C; Marmorino, F; Bergamo, F; Aprile, G; Salvatore, L; Masi, G; Dell'Aquila, E; Antoniotti, C; Murgioni, S; Allegrini, G; Borelli, B; Gemma, D; Casagrande, M; Granetto, C; Delfanti, S; Di Donato, S; Schirripa, M; Sensi, E; Tonini, G; Lonardi, S; Fontanini, G; Boni, L; Falcone, A.
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy
2019-01-01 Matrone, A.; Torregrossa, L.; Sensi, E.; Cappellani, D.; Baronti, W.; Ciampi, R.; Molinaro, E.; Ugolini, C.; Aghababyan, A.; De Napoli, L.; Latrofa, F.; Materazzi, G.; Basolo, F.; Vitti, P.; Elisei, R.
Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer
2018-01-01 Cremolini, C; Antoniotti, C; Lonardi, S; Bergamo, F; Cortesi, E; Tomasello, G; Moretto, R; Ronzoni, M; Racca, P; Loupakis, F; Zaniboni, A; Tonini, G; Buonadonna, A; Marmorino, F; Allegrini, Giuseppe; Granetto, C; Masi, G; Zagonel, V; Sensi, E; Fontanini, G; Boni, L; Falcone, A
Clinical Impact of Pretreatment EGFR T790M Mutation in Lung Adenocarcinoma Patients
2017-01-01 Macerola, Elisabetta; Bruno, Rossella; Prediletto, Irene; Sensi, Elisa; Chella, Antonio; Landi, Lorenza; Ali', Greta; Fontanini, Gabriella
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
2017-01-01 Melaiu, Ombretta; Catalano, Calogerina; DE SANTI, Chiara; Cipollini, Monica; Figlioli, Gisella; Pellè, Lucia; Barone, Elisa; Evangelista, Monica; Guazzelli, Alice; Boldrini, Laura; Sensi, Elisa; Bonotti, Alessandra; Foddis, Rudy; Cristaudo, Alfonso; Mutti, Luciano; Fontanini, Gabriella; Gemignani, Federica; Landi, Stefano
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months.
2017-01-01 Marconcini, Riccardo; Galli, L; Antonuzzo, A; Bursi, S; Roncella, C; Fontanini, Gabriella; Sensi, Elisa; Falcone, Alfredo
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma
2015-01-01 Massi, Daniela; Simi, Lisa; Sensi, Elisa; Baroni, Gianna; Xue, Gongda; Scatena, Cristian; Caldarella, Adele; Pinzani, Pamela; Fontanini, Gabriella; Carobbio, Alessandra; Urso, Carmelo; Mandalà, Mario
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer
2015-01-01 Fornaro, Lorenzo; Faviana, Pinuccia; DE GREGORIO, Veronica; Vivaldi, Caterina; Paolicchi, Elisa; Masi, Gianluca; Loupakis, Fotios; Sensi, Elisa; Lupi, Cristiana; Fontanini, Gabriella; Wang, Yuzhuo; Danesi, Romano; Falcone, Alfredo; Crea, Francesco
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer
2015-01-01 Schirripa, Marta; Cremolini, Chiara; Loupakis, Fotios; Morvillo, Manfredi; Bergamo, Francesca; Zoratto, Federica; Salvatore, Lisa; Antoniotti, Carlotta; Marmorino, Federica; Sensi, Elisa; Lupi, Cristiana; Fontanini, Gabriella; Gregorio, Veronica De; Giannini, Riccardo; Basolo, Fulvio; Masi, Gianluca; Falcone, Alfredo
ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment
2014-01-01 Alã¬, Greta; Proietti, Agnese; Pelliccioni, Serena; Niccoli, Cristina; Lupi, Cristiana; Sensi, Elisa; Giannini, Riccardo; Borrelli, Nicla; Menghi, Maura; Chella, Antonio; Ribechini, Alessandro; Cappuzzo, Federico; Melfi, Franca; Lucchi, Marco; Mussi, Alfredo; Fontanini, Gabriella
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center.
2013-01-01 D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Feasibility of BRCA1/2 testing of formalin-fixed and paraffin-embedded pancreatic tumor samples: A consecutive clinical series | 1-gen-2021 | Bruno, R.; Sensi, E.; Lupi, C.; Giordano, M.; Bernardini, L.; Vivaldi, C.; Fornaro, L.; Vasile, E.; Campani, D.; Fontanini, G. | |
| Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial | 1-gen-2019 | Cremolini, C; Marmorino, F; Bergamo, F; Aprile, G; Salvatore, L; Masi, G; Dell'Aquila, E; Antoniotti, C; Murgioni, S; Allegrini, G; Borelli, B; Gemma, D; Casagrande, M; Granetto, C; Delfanti, S; Di Donato, S; Schirripa, M; Sensi, E; Tonini, G; Lonardi, S; Fontanini, G; Boni, L; Falcone, A. | |
| The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy | 1-gen-2019 | Matrone, A.; Torregrossa, L.; Sensi, E.; Cappellani, D.; Baronti, W.; Ciampi, R.; Molinaro, E.; Ugolini, C.; Aghababyan, A.; De Napoli, L.; Latrofa, F.; Materazzi, G.; Basolo, F.; Vitti, P.; Elisei, R. | |
| Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer | 1-gen-2018 | Cremolini, C; Antoniotti, C; Lonardi, S; Bergamo, F; Cortesi, E; Tomasello, G; Moretto, R; Ronzoni, M; Racca, P; Loupakis, F; Zaniboni, A; Tonini, G; Buonadonna, A; Marmorino, F; Allegrini, Giuseppe; Granetto, C; Masi, G; Zagonel, V; Sensi, E; Fontanini, G; Boni, L; Falcone, A | |
| Clinical Impact of Pretreatment EGFR T790M Mutation in Lung Adenocarcinoma Patients | 1-gen-2017 | Macerola, Elisabetta; Bruno, Rossella; Prediletto, Irene; Sensi, Elisa; Chella, Antonio; Landi, Lorenza; Ali', Greta; Fontanini, Gabriella | |
| Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines | 1-gen-2017 | Melaiu, Ombretta; Catalano, Calogerina; DE SANTI, Chiara; Cipollini, Monica; Figlioli, Gisella; Pellè, Lucia; Barone, Elisa; Evangelista, Monica; Guazzelli, Alice; Boldrini, Laura; Sensi, Elisa; Bonotti, Alessandra; Foddis, Rudy; Cristaudo, Alfonso; Mutti, Luciano; Fontanini, Gabriella; Gemignani, Federica; Landi, Stefano | |
| Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months. | 1-gen-2017 | Marconcini, Riccardo; Galli, L; Antonuzzo, A; Bursi, S; Roncella, C; Fontanini, Gabriella; Sensi, Elisa; Falcone, Alfredo | |
| Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma | 1-gen-2015 | Massi, Daniela; Simi, Lisa; Sensi, Elisa; Baroni, Gianna; Xue, Gongda; Scatena, Cristian; Caldarella, Adele; Pinzani, Pamela; Fontanini, Gabriella; Carobbio, Alessandra; Urso, Carmelo; Mandalà, Mario | |
| Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer | 1-gen-2015 | Fornaro, Lorenzo; Faviana, Pinuccia; DE GREGORIO, Veronica; Vivaldi, Caterina; Paolicchi, Elisa; Masi, Gianluca; Loupakis, Fotios; Sensi, Elisa; Lupi, Cristiana; Fontanini, Gabriella; Wang, Yuzhuo; Danesi, Romano; Falcone, Alfredo; Crea, Francesco | |
| Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer | 1-gen-2015 | Schirripa, Marta; Cremolini, Chiara; Loupakis, Fotios; Morvillo, Manfredi; Bergamo, Francesca; Zoratto, Federica; Salvatore, Lisa; Antoniotti, Carlotta; Marmorino, Federica; Sensi, Elisa; Lupi, Cristiana; Fontanini, Gabriella; Gregorio, Veronica De; Giannini, Riccardo; Basolo, Fulvio; Masi, Gianluca; Falcone, Alfredo | |
| ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment | 1-gen-2014 | Alã¬, Greta; Proietti, Agnese; Pelliccioni, Serena; Niccoli, Cristina; Lupi, Cristiana; Sensi, Elisa; Giannini, Riccardo; Borrelli, Nicla; Menghi, Maura; Chella, Antonio; Ribechini, Alessandro; Cappuzzo, Federico; Melfi, Franca; Lucchi, Marco; Mussi, Alfredo; Fontanini, Gabriella | |
| Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. | 1-gen-2013 | D. Viola, L. Valerio; Faviana, Pinuccia; Molinaro, Eleonora; Sensi, Elisa; Agate, Laura; Materazzi, Gabriele; Basolo, Fulvio; Miccoli, Paolo; Vitti, Paolo |